Safety and Pharmacokinetic Study of a Recombinant Coagulation Factor IX Albumin Fusion Protein in Subjects With Hemophilia B

This study has been completed.
Information provided by (Responsible Party):
CSL Behring Identifier:
First received: November 2, 2010
Last updated: January 26, 2012
Last verified: January 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2011
  Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
No publications provided by CSL Behring

Publications automatically indexed to this study by Identifier (NCT Number):